Abstract
High dose chemotherapy with autologous bone marrow transplantation (ABMT) has shown promise in several types of cancer. There is, however, a risk of transfusing contaminating tumour cells with the bone marrow cells, e.g. in patients with small cell lung carcinoma (SCLC). To eliminate SCLC cells from normal human bone marrow, four monoclonal antibodies reactive with SCLC cells were used with immunomagnetic beads in model experiments. With two cycles of immunomagnetic elimination the individual antibodies removed 2.5-4.4 log of H-146 tumour cells from a single cell suspension, as assessed in a highly reproducible soft agar assay. Different combinations of two antibodies were only marginally more effective than the individual MAbs, whereas 5-6 log removal was obtained with a combination of all four antibodies. The method was equally effective when the tumour cells were mixed with bone marrow cells at a ratio of 1:10. The immunomagnetic procedure did not significantly affect the survival of normal progenitor cells, assessed in CFU-GM and CFU-GEMM assays. The results indicate that the procedure safely and effectively can be used to eliminate tumour cells from the bone marrow in conjunction with ABMT in patients with SCLC.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albain K. S., Crowley J. J., Livingston R. B. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Chest. 1991 Jun;99(6):1425–1432. doi: 10.1378/chest.99.6.1425. [DOI] [PubMed] [Google Scholar]
- Beiske K., Myklebust A. T., Aamdal S., Langholm R., Jakobsen E., Fodstad O. Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Am J Pathol. 1992 Sep;141(3):531–538. [PMC free article] [PubMed] [Google Scholar]
- Benard J., Bettan-Renaud L., Gavoille A., Pico J. L., Beaujean F., Lopez M., Riou G. In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation. Eur J Cancer Clin Oncol. 1988 Oct;24(10):1561–1566. doi: 10.1016/0277-5379(88)90045-4. [DOI] [PubMed] [Google Scholar]
- Berendsen H. H., de Leij L., Postmus P. E., Ter Haar J. G., Poppema S., The T. H. Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen. J Clin Pathol. 1988 Mar;41(3):273–276. doi: 10.1136/jcp.41.3.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burgess A. W., Wilson E. M., Metcalf D. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood. 1977 Apr;49(4):573–583. [PubMed] [Google Scholar]
- Canon J. L., Humblet Y., Lebacq-Verheyden A. M., Manouvriez P., Bazin H., Rodhain J., Prignot J., Symann M. Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies. Eur J Cancer Clin Oncol. 1988 Feb;24(2):147–150. doi: 10.1016/0277-5379(88)90245-3. [DOI] [PubMed] [Google Scholar]
- Carney D. N., Gazdar A. F., Bepler G., Guccion J. G., Marangos P. J., Moody T. W., Zweig M. H., Minna J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 1985 Jun;45(6):2913–2923. [PubMed] [Google Scholar]
- Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elias A. D., Pap S. A., Bernal S. D. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads. Prog Clin Biol Res. 1990;333:263–275. [PubMed] [Google Scholar]
- Glorieux P., Bouffet E., Philip I., Biron P., Holzapfel L., Floret D., Bouvier R., Vitrey D., Pinkerton R., Brunat-Mentigny M. Metastatic interstitial pneumonitis after autologous bone marrow transplantation. A consequence of reinjection of malignant cells? Cancer. 1986 Nov 1;58(9):2136–2139. doi: 10.1002/1097-0142(19861101)58:9<2136::aid-cncr2820580929>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Gomm S. A., Thatcher N., Cuthbert A., Chang J., Burmester H., Hall P., Carroll K. B. High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study. Br J Cancer. 1991 Feb;63(2):293–297. doi: 10.1038/bjc.1991.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gordon L. I., Rosen S. T., Vriesendorp H. M., Kies M. S., Kucuk O. Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines. Cancer Res. 1984 Nov;44(11):5404–5408. [PubMed] [Google Scholar]
- Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. J. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med. 1991 Nov 28;325(22):1525–1533. doi: 10.1056/NEJM199111283252201. [DOI] [PubMed] [Google Scholar]
- Humblet Y., Feyens A. M., Sekhavat M., Agaliotis D., Canon J. L., Symann M. L. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts. Cancer Res. 1989 Sep 15;49(18):5058–5061. [PubMed] [Google Scholar]
- Humblet Y., Symann M., Bosly A., Delaunois L., Francis C., Machiels J., Beauduin M., Doyen C., Weynants P., Longueville J. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol. 1987 Dec;5(12):1864–1873. doi: 10.1200/JCO.1987.5.12.1864. [DOI] [PubMed] [Google Scholar]
- Kiesel S., Haas R., Moldenhauer G., Kvalheim G., Pezzutto A., Dörken B. Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis. Leuk Res. 1987;11(12):1119–1125. doi: 10.1016/0145-2126(87)90166-4. [DOI] [PubMed] [Google Scholar]
- Kvalheim G., Fodstad O., Pihl A., Nustad K., Pharo A., Ugelstad J., Funderud S. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Res. 1987 Feb 1;47(3):846–851. [PubMed] [Google Scholar]
- Kvalheim G., Sørensen O., Fodstad O., Funderud S., Kiesel S., Dörken B., Nustad K., Jakobsen E., Ugelstad J., Pihl A. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Bone Marrow Transplant. 1988 Jan;3(1):31–41. [PubMed] [Google Scholar]
- Lazarus H. M., Spitzer T. R., Creger R. J. Phase I trial of high-dose etoposide, high-dose cisplatin, and reinfusion of autologous bone marrow for lung cancer. Am J Clin Oncol. 1990 Apr;13(2):107–112. doi: 10.1097/00000421-199004000-00004. [DOI] [PubMed] [Google Scholar]
- Mabry M., Speak J. A., Griffin J. D., Stahel R. A., Bernal S. D. Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung. J Clin Invest. 1985 May;75(5):1690–1695. doi: 10.1172/JCI111877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marangolo M., Rosti G., Amadori D., Leoni M., Ardizzone A., Fiorentini G., Cruciani G., Tienghi A., Ravaioli A., Sebastiani L. High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot study. Bone Marrow Transplant. 1989 Jul;4(4):405–408. [PubMed] [Google Scholar]
- Meagher R. C., Rothman S. A., Paul P., Koberna P., Willmer C., Baucco P. A. Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment. Cancer Res. 1989 Jul 1;49(13):3637–3641. [PubMed] [Google Scholar]
- Messner H. A., Jamal N., Izaguirre C. The growth of large megakaryocyte colonies from human bone marrow. J Cell Physiol Suppl. 1982;1:45–51. doi: 10.1002/jcp.1041130410. [DOI] [PubMed] [Google Scholar]
- Moolenaar C. E., Muller E. J., Schol D. J., Figdor C. G., Bock E., Bitter-Suermann D., Michalides R. J. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res. 1990 Feb 15;50(4):1102–1106. [PubMed] [Google Scholar]
- Myklebust A. T., Beiske K., Pharo A., Davies C. D., Aamdal S., Fodstad O. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer Suppl. 1991 Jun;14:49–53. [PMC free article] [PubMed] [Google Scholar]
- Nomura F., Shimokata K., Saito H., Watanabe A., Saka H., Sakai S., Kodera Y., Saito H. High dose chemotherapy with autologous bone marrow transplantation for limited small cell lung cancer. Jpn J Clin Oncol. 1990 Mar;20(1):94–98. [PubMed] [Google Scholar]
- Okabe T., Kaizu T., Fujisawa M., Watanabe J., Kojima K., Yamashita T., Takaku F. Monoclonal antibodies to surface antigens of small cell carcinoma of the lung. Cancer Res. 1984 Nov;44(11):5273–5278. [PubMed] [Google Scholar]
- Okabe T., Kaizu T., Ozawa K., Urabe A., Takaku F. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody. Cancer Res. 1985 May;45(5):1930–1933. [PubMed] [Google Scholar]
- Ripamonti M., Canevari S., Ménard S., Mezzanzanica D., Miotti S., Orlandi R., Rilke F., Tagliabue E., Colnaghi M. I. Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model. Cancer Immunol Immunother. 1987;24(1):13–18. doi: 10.1007/BF00199827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Souhami R. L., Hajichristou H. T., Miles D. W., Earl H. M., Harper P. G., Ash C. M., Goldstone A. H., Spiro S. G., Geddes D. M., Tobias J. S. Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer. Cancer Chemother Pharmacol. 1989;24(5):321–325. doi: 10.1007/BF00304766. [DOI] [PubMed] [Google Scholar]
- Stahel R. A., Mabry M., Skarin A. T., Speak J., Bernal S. D. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol. 1985 Apr;3(4):455–461. doi: 10.1200/JCO.1985.3.4.455. [DOI] [PubMed] [Google Scholar]
- Trillet V., Revel D., Combaret V., Favrot M., Loire R., Tabib A., Pages J., Jacquemet P., Bonmartin A., Mornex J. F. Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies. Br J Cancer. 1989 Jul;60(1):83–88. doi: 10.1038/bjc.1989.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vredenburgh J. J., Ball E. D. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads. Cancer Res. 1990 Nov 15;50(22):7216–7220. [PubMed] [Google Scholar]
- Wang M. Y., Kvalheim G., Kvaløy S., Beiske K., Jakobsen E., Wijdenes J., Pihl A., Fodstad O. An effective immunomagnetic method for bone marrow purging in T cell malignancies. Bone Marrow Transplant. 1992 May;9(5):319–323. [PubMed] [Google Scholar]
- Williams S. F., Bitran J. D., Hoffman P. C., Robin E., Fullem L., Beschorner J., Golick J., Golomb H. M. High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer. Cancer. 1989 Jan 15;63(2):238–242. doi: 10.1002/1097-0142(19890115)63:2<238::aid-cncr2820630206>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
- de Leij L., Poppema S., Nulend J. K., ter Haar A., Schwander E., Ebbens F., Postmus P. E., The T. H. Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res. 1985 May;45(5):2192–2200. [PubMed] [Google Scholar]